Knowthestock.com
BAX - Baxter International Inc.

Sell

Weak GrowthStock Price Very High
WeakStrong
WeakStrong

38%

based on last 5 year data.
Income Statement is MODERATE
Revenue Growth is 34.13%
Operating Income turning Positive
Net Income turning Positive
Earnings Per Share (EPS) turning Positive
Net Margin is 16.51%
Balance Sheet is WEAK
Current Asset to Current Liability Ratio is 1.4
Debt Ratio is 0.71
Current Debt to Net Income Ratio not available
Total Debt to Total Assets Ratio is 0.49
Cash Flow is MODERATE
Cash from Operations Growth is -21.31%
Capital Expenditure is Low
Net Increase in Cash is Positive
Long Term Score Trend is POSITIVE
Investment Risk is High
based on last 4 quarter data.
Better viewed in landscape mode.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.
Baxter International Inc. (BAX) - https://www.baxter.com/
baxter provides a broad portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile iv solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software and services. the company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that enable patient care.
Exchange - NEW YORK STOCK EXCHANGE INC.
Industry - Surgical and Medical Instrument Manufacturing
Sector - Manufacturing
CEO - Jose Almeida
Employees - 32,403
    Close

    Login/Register

    Home


Cookie Policy
Disclaimer - Investment in securities involves substantial risk and could result in significant loss. It is not suitable for every investor. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. We may own some of the securities mentioned in this website.
Know the Stock © 2024 and future.